Acute Respiratory Distress Syndrome Clinical Trial
Official title:
Feeding the Critically Ill During Phases of Altered Redox Status (FEDOX): a Prospective Randomized Trial
The FEDOX trial is a prospective randomized clinical trial exploring oxidative stress as a
mechanism of harm to explain the negative outcomes found in feeding trials that achieved
caloric exposure commensurate with the nationally recommended guidelines. Due to its impact
on energy metabolism, we will also explore low T3 syndrome's relationship to this mechanism.
Finally, we will explore circadian patterns of diurnal/nocturnal TSH fluctuation as a
potential biomarker to indicate this mechanism of harm has subsided.
This 7-day prospective randomized clinical trial is designed to address the following
specific aims (SA) in ICU patients (n=40) with systemic inflammatory response syndrome.
SA1) Determine whether provision of enteral nutrition (EN) at 100% of levels in Nationally
Recommended Guidelines NRG (25-30 kcals/kg, 100%NRG) early in critical illness increases
reactive oxygen species (ROS) production compared to EN at 40% of NRG levels (10-12 kcals/kg,
40%NRG). Subjects will be fasted overnight and randomized to receive either 100% NRG or
40%NRG for 7 days. Plasma F2-isoprostanes will be measured daily and compared between groups
through repeated measures analysis.
SA2) Determine if EN at 100%NRG interrupts the critical illness induced low T3 syndrome and
subsequently further increases the ROS production compared to 40%NRG. Serum thyroid
parameters (T3, T4, rT3, TSH) with be measured daily and compared between groups as above.
Mediation analysis will be used to determine the proportion of the effect of nutrition group
on F2-isoprostane production explained by each thyroid parameter.
SA3) Determine if the return of diurnal/noctural fluctuations in TSH is associated with
decreased nutrition-induced ROS production. Plasma TSH will be measured twice per day at 0300
and 1800hrs to determine TSH fluctuation. The interaction effect between TSH fluctuation and
nutrition group on F2-isoprostane production will be assessed through repeated measures
analysis. This study provides vital mechanistic insight into the impact of feeding on
oxidative stress during the first week of critical illness, represents an important first
step in determining the safest timing and dosage of nutrition support, and sets the
foundation for future larger clinical trials on these topics.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04384445 -
Zofin (Organicell Flow) for Patients With COVID-19
|
Phase 1/Phase 2 | |
Recruiting |
NCT05535543 -
Change in the Phase III Slope of the Volumetric Capnography by Prone Positioning in Acute Respiratory Distress Syndrome
|
||
Completed |
NCT04695392 -
Restore Resilience in Critically Ill Children
|
N/A | |
Terminated |
NCT04972318 -
Two Different Ventilatory Strategies in Acute Respiratory Distress Syndrome Due to Community-acquired Pneumonia
|
N/A | |
Completed |
NCT04534569 -
Expert Panel Statement for the Respiratory Management of COVID-19 Related Acute Respiratory Failure (C-ARF)
|
||
Completed |
NCT04078984 -
Driving Pressure as a Predictor of Mechanical Ventilation Weaning Time on Post-ARDS Patients in Pressure Support Ventilation.
|
||
Completed |
NCT04451291 -
Study of Decidual Stromal Cells to Treat COVID-19 Respiratory Failure
|
N/A | |
Not yet recruiting |
NCT06254313 -
The Role of Cxcr4Hi neutrOPhils in InflueNza
|
||
Not yet recruiting |
NCT04798716 -
The Use of Exosomes for the Treatment of Acute Respiratory Distress Syndrome or Novel Coronavirus Pneumonia Caused by COVID-19
|
Phase 1/Phase 2 | |
Withdrawn |
NCT04909879 -
Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells for Non-COVID-19 Acute Respiratory Distress Syndrome
|
Phase 2 | |
Not yet recruiting |
NCT02881385 -
Effects on Respiratory Patterns and Patient-ventilator Synchrony Using Pressure Support Ventilation
|
N/A | |
Terminated |
NCT02867228 -
Noninvasive Estimation of Work of Breathing
|
N/A | |
Completed |
NCT02545621 -
A Role for RAGE/TXNIP/Inflammasome Axis in Alveolar Macrophage Activation During ARDS (RIAMA): a Proof-of-concept Clinical Study
|
||
Withdrawn |
NCT02253667 -
Palliative Use of High-flow Oxygen Nasal Cannula in End-of-life Lung Disease Patients
|
N/A | |
Completed |
NCT02232841 -
Electrical Impedance Imaging of Patients on Mechanical Ventilation
|
N/A | |
Withdrawn |
NCT01927237 -
Pulmonary Vascular Effects of Respiratory Rate & Carbon Dioxide
|
N/A | |
Completed |
NCT01504893 -
Very Low Tidal Volume vs Conventional Ventilatory Strategy for One-lung Ventilation in Thoracic Anesthesia
|
N/A | |
Completed |
NCT02889770 -
Dead Space Monitoring With Volumetric Capnography in ARDS Patients
|
N/A | |
Completed |
NCT01680783 -
Non-Invasive Ventilation Via a Helmet Device for Patients Respiratory Failure
|
N/A | |
Completed |
NCT02814994 -
Respiratory System Compliance Guided VT in Moderate to Severe ARDS Patients
|
N/A |